Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
June 25, 2024 08:30 ET
|
Kannalife Sciences, Inc.
Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has developed a new class of orally bioavailable...